Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv in children and adolescents with ADHD (fMRI study)
NCT01709695Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Icahn School of Medicine at Mount Sinai. Started Mar 2011; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01709695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709695.